May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Diagnostic Accuracy of the GDx VCC in the Diagnosis of Glaucoma
Author Affiliations & Notes
  • R.H. C. Zegers
    Glaucoma Service, The Rotterdam Eye Hospital, Rotterdam, The Netherlands
    Dept. of Ophthalmology, Amsterdam Medical Center, Amsterdam, The Netherlands
  • N.J. Reus
    Glaucoma Service, The Rotterdam Eye Hospital, Rotterdam, The Netherlands
  • H.G. Lemij
    Glaucoma Service, The Rotterdam Eye Hospital, Rotterdam, The Netherlands
  • Footnotes
    Commercial Relationships  R.H.C. Zegers, Laser Diagnostic Technologies, Inc. F; N.J. Reus, Laser Diagnostic Technologies, Inc. F; H.G. Lemij, Laser Diagnostic Technologies, Inc. F, C.
  • Footnotes
    Support  The Rotterdam Eye Hospital Research Foundation; Stichting Glaucoomfonds
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 3323. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R.H. C. Zegers, N.J. Reus, H.G. Lemij; Diagnostic Accuracy of the GDx VCC in the Diagnosis of Glaucoma . Invest. Ophthalmol. Vis. Sci. 2004;45(13):3323.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To determine the diagnostic accuracy of the GDx VCC in the diagnosis of glaucoma. Methods: The GDx VCC, a commercially available scanning laser polarimeter, estimates retinal nerve fiber layer (RNFL) thickness by measuring the summed retardation of a polarized laser beam induced by the birefringent RNFL. The instrument is equipped with automated individualized compensation of anterior segment birefringence. One eye each of 156 patients with primary open–angle glaucoma and 77 age–matched healthy subjects of Caucasian ethnic origin were measured with the GDx VCC (Laser Diagnostic Technologies, Inc., San Diego, CA, USA). All glaucoma patients had a reproducible glaucomatous visual field defect (mean mean deviation (MD), –8.69 dB) and a glaucomatous appearance of the optic disc in at least one eye. Healthy subjects had normal visual fields (mean MD, 0.39 dB), healthy–looking optic discs, and intraocular pressures ≤21 mmHg in both eyes. We constructed receiver operating characteristic (ROC) curves for the parameters TSNIT Average, Superior Average, Inferior Average, TSNIT SD, and Nerve Fiber Indicator (NFI). At a fixed specificity of 96%, we determined the sensitivity for the best discriminating parameter in the entire group of patients and in patients with mild (mean MD, –2.84 dB), moderate (mean MD, –8.64 dB), and severe (mean MD, –18.46 dB) glaucomatous damage, separately. Results: The areas under the ROC curves (95% confidence interval) for TSNIT Average, Superior Average, Inferior Average, TSNIT SD, and NFI were 0.93 (0.90–0.96), 0.94 (0.91–0.97), 0.90 (0.86–0.94), 0.92 (0.88–0.96), and 0.98 (0.97–1.00), respectively. The NFI, the best discriminating parameter, had an overall sensitivity and specificity of 89% and 96%, respectively, at a cutoff point of ≥40. At this cutoff level, the sensitivities for correctly identifying glaucoma patients with mild, moderate, and severe damage were 85%, 87%, and 100%, respectively. Conclusions: The GDx VCC allowed easy, rapid, and accurate discrimination between healthy and glaucomatous eyes. The NFI was the best discriminating parameter. We think that the GDx VCC fulfills criteria for a glaucoma screening device.

Keywords: imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • nerve fiber layer • imaging/image analysis: clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×